Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTC299 in Hospitalized COVID-19
NCT04439071Phase 3Terminated
- Sponsor
- PTC Therapeutics, Inc.
- Start
- Jul 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 3 trial of emvododstat in coronavirus disease 2019 (COVID-19), sponsored by PTC Therapeutics, Inc.. Started Jul 2020; status: terminated.
02
Drugs
emvododstat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04439071.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04439071.